Результаты поиска

Evolution of treatment practices and outcomes in multiple myeloma during 2013-2022: a Finnish real world registry study.

Background and purposeMultiple myeloma (MM) is a heterogenous hematologic malignancy with an evolving treatment landscape. This Finnish real-world evidence study clarifies the evolution of treatment practices and outcomes over recent years.MethodsThis retrospective analysis included 1,733 patients with MM diagnosed between 2013 and 2022. The cohort was identified and electronic health record data were collected from four hospital data lakes and linked to national registries, covering 54% of Finland's population. Patients were divided by stem cell transplantation (SCT) status into a SCT group (

Ten years of AMNOG from an oncological perspective: new horizons and continuing expansion.

Purpose2021 marks the tenth anniversary of the AMNOG process and brought with it a new German administration-two good reasons to take stock of where we stand today, what has been achieved so far, and how the path of early benefit assessments in Germany should continue.ResultsFrom the perspective of manufacturers of cancer drugs, the AMNOG process, as a constantly evolving system, has for the most part proved itself-which does not mean that there is no longer room for improvement. Significant improvements have been achieved in the area of early consultation of medical societies regarding the se

Incidence and Independent Risk Factors of Spinal Infection After Vertebral Augmentation: A Multicenter Propensity-Matched Case-Control Study.

OBJECTIVE: This study aimed to determine the incidence of spinal infection after vertebral augmentation (SIAVA) and identify its independent risk factors. METHODS: This multicenter, retrospective case-control study included patients who underwent percutaneous vertebral augmentation (PVA) for osteoporotic vertebral compression fractures at 4 centers between January 2015 and December 2021. Each SIAVA case was matched with 3 controls using propensity score matching based on demographic and clinical variables. LASSO (least absolute shrinkage and selection operator) regression was used for variabl

The innate defenders: a review of natural killer cell immunotherapies in cancer.

Cancer is a condition that has been with us for centuries; however, the therapies that have been developed are often associated with significant toxicity and various side effects. Recent advances in immunology have revealed the potential of the immune system to fight cancer, leading to the emergence of immunotherapy. This review focuses on Natural Killer (NK) cells, innate immune effectors with a remarkable ability to directly kill cancer cells. We will explore the historical context of cancer treatment, the nature of NK cells, and the ways they have been developed to enhance their anti-tumor

An Innovative Patient Stratification Tool Integrating Clinical and Economic Data for Benchmarking Oncology and Hematology Care: The PATONCOS System.

Background: The growing complexity and cost of oncohematological treatments has created an urgent need for standardized methodologies capable of enabling inter-institutional comparisons of healthcare expenditure within homogeneous patient groups. Cancer-related pharmaceutical costs vary substantially depending on tumour type, disease stage, and therapeutic approach, making cross-institutional benchmarking challenging due to heterogeneity in patient populations and clinical practice patterns. Therefore, integrating cost analysis with clinically meaningful patient stratification is essential to

The combination therapy with venetoclax in therapeutic strategy of acute lymphoblastic leukemia.

BACKGROUND: Acute lymphoblastic leukemia (ALL) is characterized by the malignant transformation and proliferation of lymphoid progenitor cells in the bone marrow, blood, and extramedullary sites. Leukemic cells can develop drug resistance both before and after treatment, complicating disease management. Combination therapy with Venetoclax has been shown to enhance the efficacy of standard anti-leukemia drugs. Therefore, this study aims to review combination treatment strategies as potential therapeutic alternatives, drawing on evidence from previous published literature. METHODS: This narrativ

Периоперативные соображения для пациентов с множественной миеломой.

Множественная миелома — неизлечимый рак, характеризующийся распространением клональных плазменных клеток, в основном в костном мозге, но вызывающий широкомасштабные системные осложнения. Кроме того, этот рак обычно встречается у пожилых пациентов, которые часто являются слабыми и страдают от многочисленных коморбидов. Общемировая распространенность множественной миеломы неуклонно возрастает, а терапевтические достижения способствуют повышению уровня выживания. Существует несколько осложнений миеломы, о которых анестезиолог должен знать в связи с самим заболеванием, конкретными и подкрепляющими

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study.

BackgroundMyelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) are myeloid neoplasms in which outgrowth of neoplastic clones disrupts normal hematopoiesis. Some patients with unexplained persistent cytopenias may not meet minimal diagnostic criteria for MDS but an alternate diagnosis is not apparent; the term idiopathic cytopenia of undetermined significance (ICUS) has been used to describe this state. MDS and AML occur primarily in older patients who are often treated outside the clinical trial setting. Consequently, our understanding of the patterns of diagnostic evaluation, mana

The Role of Endoplasmic Reticulum Stress and Unfolded Protein Response in Gynecological Cancers: A Narrative Review.

The unfolded protein response (UPR) mediated by IRE1/XBP1, PERK/eIF2α/ATF4, and ATF6/GRP78 governs tumor adaptation to hypoxia, nutrient deprivation, and therapy stress. In gynecologic malignancies (ovarian, endometrial, cervical), persistent endoplasmic reticulum (ER)-stress signaling underlies proliferation, invasion, immune evasion, and treatment resistance but also creates druggable liabilities. We conducted a narrative review of peer-reviewed literature indexed in MEDLINE (PubMed), Embase, Scopus, and Web of Science from inception through 13 September 2025. Search terms combined ER-stress

фазы 2 Судебный процесс над Фрексалимабом, антагонистом CD40L, среди подростков и взрослых с недавним-оффсетным типом 1 Диабет (ФАБУЛИНУС): Обоснование и проект исследований.

Введение 1 диабет (T1D) — хроническое аутоиммунное заболевание, характеризующееся постепенным уничтожением инсулиновых β-клеток. Сохранение оставшихся β-клеток на момент диагностики может улучшить долгосрочные результаты. Frexalib — это гуманная моноклональная антитела, специально предназначенная для CD40L, которая проходит оценку на предмет лечения различных иммунизированных заболеваний. фазы 2 - испытание для оценки эффективности и безопасности фрексалимаб для сохранения поджелудочной функции β-клетки у подростков и молодых взрослых (12-35 с недавно поставленным диагнозом " Этап "

Real-world treatment utilization in adults with chronic inflammatory demyelinating polyneuropathy in the United States.

BackgroundManagement of chronic inflammatory demyelinating polyneuropathy (CIDP) is challenged by heterogeneity in severity, comorbidities, potential adverse effects, and treatment accessibility. This study aimed to elucidate treatment utilization among patients with CIDP in the United States (US) to identify potential unmet needs.MethodsAdult patients with CIDP were identified using Komodo Health's Healthcare Map™ (January 2016-December 2020). Descriptive statistics related to utilization of CIDP treatments over 1-year post-index were analyzed. Among patients who used immunoglobulin (Ig), chr

Совпадение в полном тексте источника
… Even with chronic Ig use, steroids may be needed as a bridge therapy to manage CIDP symptoms between Ig courses. …

The Effect of Bisphosphonates on Fracture Healing Time and Changes in Bone Mass Density: A Meta-Analysis.

BackgroundOsteoporosis is a common complication of acute fracture, which can lead to fracture delayed union or other complications and resulting in poor fracture healing. Bisphosphate is a common anti-osteoporosis drug, but its application in fracture patients is still controversial because of its inhibitory effect on bone resorption.MethodStudies were acquired from literature databases in accordance with established inclusion criteria. Standard mean difference (SMD) and 95% confidence intervals (Cls) were calculated to evaluate the effectiveness of the bisphosphonates treatment in fracture pa

Клинические особенности и лечение недавно диагностированной миеломы с вторичным миэлофиброзом: ретроспективное исследование.

Вторичный миэлофиброз (СМФ) характеризуется чрезмерным осаждением волокнистых тканей сверху первичной болезни, что часто приводит к затмению клинических проявлений первичным заболеванием. К сожалению, нынешние системы сборки не включают миэлофиброз, что ведет к потенциальным задержкам в лечении SMF. Оценить прогнозы пациентов с множественной миеломой (ММ), сложной с миэлофиброзом.DESIGN: Исследование включало клинические данные и результаты лечения 208 недавно диагностированные несколько пациентов, страдающих миеломой (НДММ), которые с января лечились в аффилированной больнице Университета Цин

Использование данных о реальных требованиях для оценки распространенности конкомитативных лекарств для информирования о риске взаимодействия между наркотиками и наркотиками среди целевых групп пациентов.

Одной из общих проблем в области развития клинических наркотиков является взаимодействие между наркотиками и наркотиками (ДДИ), которое может привести к изменению воздействия наркотиков и последующему изменению безопасности и эффективности следственного препарата или сопутствующих ему лекарственных препаратов (кондекций) среди целевой группы пациентов. Таким образом, трубопровод для разработки лекарств включает оценку рисков, связанных с диагностикой наркотиков, на основе исследований in vitro, моделирования силико и клинических испытаний. Данные о реальном мире (ДСР), в частности базы данных

Incidence of type 2 diabetes, cardiovascular disease and chronic kidney disease in patients with multiple sclerosis initiating disease-modifying therapies: Retrospective cohort study using a frequentist model averaging statistical framework.

Researchers are increasingly using insights derived from large-scale, electronic healthcare data to inform drug development and provide human validation of novel treatment pathways and aid in drug repurposing/repositioning. The objective of this study was to determine whether treatment of patients with multiple sclerosis with dimethyl fumarate, an activator of the nuclear factor erythroid 2-related factor 2 (Nrf2) pathway, results in a change in incidence of type 2 diabetes and its complications. This retrospective cohort study used administrative claims data to derive four cohorts of adults w

Classical Hodgkin Lymphoma: From Past to Future-A Comprehensive Review of Pathophysiology and Therapeutic Advances.

Hodgkin lymphoma, a hematological malignancy of lymphoid origin that typically arises from germinal-center B cells, has an excellent overall prognosis. However, the treatment of patients who relapse or develop resistant disease still poses a substantial clinical and research challenge, even though current risk-adapted and response-based treatment techniques produce overall survival rates of over 95%. The appearance of late malignancies after the successful cure of primary or relapsed disease continues to be a major concern, mostly because of high survival rates. Particularly in pediatric HL pa

Natural killer cell engagers for cancer immunotherapy.

This review article explores the rapidly evolving field of bi-, tri-, and multi-specific NK cell engagers (NKCEs), highlighting their potential as a cutting-edge approach in cancer immunotherapy. NKCEs offer a significant advancement over conventional monoclonal antibodies (mAbs) by enhancing Antibody-Dependent Cellular Cytotoxicity (ADCC). They achieve this by stably and selectively binding to both NK cell activating receptors and tumor-associated antigens (TAAs). Unlike traditional mAbs, which depend on the relatively transient interaction between their Fc region and CD16a, NKCEs establish m

Изучение восприятия физической активности лиц, недавно диагностированных с множественным склерозом.

Справочная информация: Физическая активность имеет важное значение для повышения качества жизни лиц с множественным склерозом (МС). Вместе с тем имеются лишь ограниченные данные об уникальных барьерах, с которыми лица, недавно диагностированные с помощью MS, сталкиваются. Цель этого качественного исследования состоит в том, чтобы понять взгляды лиц, недавно диагностировавших НР, на физическую активность. Методы: Было проведено четыре целевых группы с лицами, недавно диагностировавшими НР (n = 12). Участникам были заданы открытые вопросы, связанные с барьерами и посредниками физической активнос

Синдром неспокойных ног: сетевая модель нейромодуляции железа-депендента-Нарративный обзор.

Синдром нервных ног (RLS) традиционно концептуализируется как сенсорное расстройство, реагирующее на допамин; однако новые данные говорят о более сложной и неоднородной нейробиологической основе. Результаты нейроимации, генетических исследований, циркадийской биологии и клинических исследований свидетельствуют о том, что допаминергическая дисфункция происходит в более широком контексте нейромодуляционного дисбаланса, включая метаболизм железа, аденозингергическую сигнализацию, глютаматергию и, возможно, норадренергические пути. Наряду с этим количественное картирование уязвимости и связанные с

The association between financial toxicity and mortality in hematologic malignancies: a systematic review and meta-analysis.

BackgroundHematologic malignancies impose substantial economic burdens, but the quantitative association between financial toxicity and overall survival remains poorly defined across diverse clinical settings and disease lineages.MethodsAdhering to PRISMA and MOOSE guidelines, we searched electronic databases through January 2026 for studies reporting multivariable-adjusted hazard ratios (aHRs) for the association between financial toxicity and mortality in adults diagnosed with hematologic malignancies. A random-effects model with Hartung-Knapp adjustment was used for data synthesis. Small-st